# ADVATE Post Authorization Safety Surveillance

> **NCT00214734** · — · COMPLETED · sponsor: **Baxalta now part of Shire** · enrollment: 108 (actual)

## Conditions studied

- Hemophilia A

## Interventions

- **DRUG:** rAHF-PFM

## Key facts

- **NCT ID:** NCT00214734
- **Lead sponsor:** Baxalta now part of Shire
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2004-10-14
- **Primary completion:** —
- **Final completion:** 2007-03-02
- **Target enrollment:** 108 (ACTUAL)
- **Last updated:** 2021-03-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00214734

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00214734, "ADVATE Post Authorization Safety Surveillance". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00214734. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*